Opus Genetics (IRD) Current Assets (2010 - 2026)

Opus Genetics (IRD) has 17 years of Current Assets data on file, last reported at $66.6 million in Q1 2026.

• Quarterly Current Assets rose 38.96% year-over-year to $66.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $66.6 million (up 38.96% YoY) and the FY2025 annual result came in at $50.0 million, up 36.69% from the prior year.
• Current Assets advanced to $66.6 million in Q1 2026 per IRD's latest filing, from $50.0 million in the prior quarter.
• Across five years, Current Assets topped out at $66.6 million in Q1 2026 and bottomed at $14.6 million in Q3 2022.
• The 5-year median for Current Assets is $44.8 million (2024), against an average of $41.9 million.
• The widest annual swing landed in 2022, when Current Assets plunged 37.22%; it then jumped 272.14% in 2023.
• Tracing IRD's Current Assets over 5 years: stood at $49.0 million in 2022, then increased by 10.13% to $53.9 million in 2023, then tumbled by 32.14% to $36.6 million in 2024, then jumped by 36.69% to $50.0 million in 2025, then jumped by 33.08% to $66.6 million in 2026.
• Per Business Quant, the three latest IRD Current Assets figures stand at $66.6 million (Q1 2026), $50.0 million (Q4 2025), and $35.9 million (Q3 2025).

Peer Comparison